These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 938151

  • 1. [Factors influenceing the activity of oral anticoagulants].
    González Caamaño A, Díaz Barreiro LA.
    Arch Inst Cardiol Mex; 1976; 46(1):59-68. PubMed ID: 938151
    [Abstract] [Full Text] [Related]

  • 2. Drug interactions involving oral anticoagulants.
    O'Reilly RA.
    Cardiovasc Clin; 1974; 6(2):23-41. PubMed ID: 4613460
    [No Abstract] [Full Text] [Related]

  • 3. [Pharmacokinetics of 4-hydroxycoumarin derivative anticoagulants (a review of the literature)].
    Lakin KM, Krylov IuF, Kuperman AV, Grenaderov SIu.
    Farmakol Toksikol; 1981; 44(4):484-94. PubMed ID: 7026279
    [No Abstract] [Full Text] [Related]

  • 4. The pharmacodynamics of the oral anticoagulant drugs.
    O'Reilly RA.
    Prog Hemost Thromb; 1974; 2(0):175-213. PubMed ID: 4137288
    [No Abstract] [Full Text] [Related]

  • 5. [Factors influencing activity of oral anticoagulants. Interactions with drugs and food].
    Sawicka-Powierza J, Rogowska-Szadkowska D, Ołtarzewska AM, Chlabicz S.
    Pol Merkur Lekarski; 2008 May; 24(143):458-62. PubMed ID: 18634396
    [Abstract] [Full Text] [Related]

  • 6. [Resistance to vitamin K antagonists. 6 cases].
    Lefrère JJ, Guyon F, Horellou MH, Conard J, Samama M.
    Ann Med Interne (Paris); 1986 May; 137(5):384-90. PubMed ID: 3813270
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacokinetic aspects of overdosage and intoxication with oral anticoagulant drugs (author's transl)].
    Jähnchen E, Meinertz T.
    Arzneimittelforschung; 1977 May; 27(96):1849-56. PubMed ID: 303522
    [Abstract] [Full Text] [Related]

  • 8. Oral anticoagulant drugs: pharmacokinetic aspects.
    Breckenridge A.
    Semin Hematol; 1978 Jan; 15(1):19-26. PubMed ID: 341326
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Interactions between chemotherapeutics and other drugs].
    Witkowska M, Prandota J.
    Postepy Hig Med Dosw; 1976 Jan; 30(6):845-59. PubMed ID: 1023173
    [No Abstract] [Full Text] [Related]

  • 11. Clinically significant drug interactions with the oral anticoagulants.
    Freedman MD, Olatidoye AG.
    Drug Saf; 1994 May; 10(5):381-94. PubMed ID: 8037888
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
    Chan E, Hegde A, Chen X.
    J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
    [Abstract] [Full Text] [Related]

  • 14. Determinants of the response to oral anticoagulant drugs in man.
    O'Reilly RA, Aggeler PM.
    Pharmacol Rev; 1970 Mar; 22(1):35-96. PubMed ID: 4918964
    [No Abstract] [Full Text] [Related]

  • 15. [The effect of drugs on the treatment with oral anticoagulants].
    Loeliger EA.
    Ned Tijdschr Geneeskd; 1973 Sep 15; 117(37):1396-9. PubMed ID: 4787075
    [No Abstract] [Full Text] [Related]

  • 16. [Adverse reactions of coumarin derivative interactions].
    Wiela-Hojeńska A, Orzechowska-Juzwenko K.
    Pol Merkur Lekarski; 2000 Sep 15; 9(51):600-1. PubMed ID: 11126983
    [Abstract] [Full Text] [Related]

  • 17. Interference with oral anticoagulant treatment by oestrogen--influence of oestrogen administration route.
    Cotton F, Sorlin P, Corvilain B, Fockedey JM, Capel P.
    Thromb Haemost; 1999 Mar 15; 81(3):471-2. PubMed ID: 10102486
    [No Abstract] [Full Text] [Related]

  • 18. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V.
    Semin Thromb Hemost; 2006 Nov 15; 32(8):781-6. PubMed ID: 17171590
    [Abstract] [Full Text] [Related]

  • 19. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease.
    Shorr RI, Ray WA, Daugherty JR, Griffin MR.
    Arch Intern Med; 1993 Jul 26; 153(14):1665-70. PubMed ID: 8333804
    [Abstract] [Full Text] [Related]

  • 20. Investigation on recombinant hirudin via oral route.
    Cen X, Ni J, Tan T, Liu X, Li C, Chen J, Huang Y, Zhu S, Bi Q.
    Peptides; 2006 Apr 26; 27(4):836-40. PubMed ID: 16469415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.